Display options
Share it on

BMC Nephrol. 2020 Nov 25;21(1):506. doi: 10.1186/s12882-020-02151-7.

The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis.

BMC nephrology

Misghina Weldegiorgis, Mark Woodward

Affiliations

  1. The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. [email protected].
  2. The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia. [email protected].
  3. The George Institute for Global Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  4. The George Institute for Global Health, University of New South Wales Sydney, Sydney, Australia.
  5. Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA.

PMID: 33238919 PMCID: PMC7687699 DOI: 10.1186/s12882-020-02151-7

Abstract

BACKGROUND: Hypertension (HTN) is an established risk factor for chronic kidney disease (CKD) and end-stage renal disease (ESRD). Whether sex differences in the effect of HTN on CKD and ESRD incidence exist remains unclear. This systematic review and meta-analysis was conducted to evaluate the relative impact of HTN on CKD and ESRD risk in women compared with men.

METHODS: We systematically searched Embase and PubMed for cohort studies until 24 July 2020. Studies were selected if they reported a sex-specific association between systolic blood pressure (SBP) and CKD or ESRD. Random effects meta-analyses with inverse variance weighting were used to pool sex-specific relative risks (RRs) and the women-to-men ratio of RRs (the RRR) for incident CKD and ESRD.

RESULTS: Data from six cohorts, including 2,382,712 individuals and 6856 incident CKD events, and 833 ESRD events, were included in the meta-analysis. The RR for incident CKD or ESRD associated with HTN (SBP ≥140 mmHg) versus ideal BP (SBP < 120 mmHg) was 1.56 (95% CI, 1.39-1.75) in women and 2.06 (95% CI, 1.64-2.60) in men. The RR for incident CKD or ESRD was 23% lower in women than in men RRR 0.77 [95% CI, 0.63-0.95] with no significant heterogeneity between studies (p-value for Q test = 0.507, I

CONCLUSION: HTN confers about a fifth lower excess risk of incident CKD or ESRD in women than men. Sex differences in onset, duration, and severity of some risk factors, such as albuminuria, diabetes, cardiovascular disease, obesity, and socioeconomic status, may explain part of the excess risk in men. Another explanation could be that women might be under-diagnosed and less likely to initiate dialysis. Future studies are needed to demonstrate the mechanisms responsible for the observed sex difference.

References

  1. BMJ. 2013 Jan 29;346:f324 - PubMed
  2. Am J Kidney Dis. 2013 Mar;61(3):413-9 - PubMed
  3. Am J Kidney Dis. 2016 Jan;67(1):89-97 - PubMed
  4. Nat Rev Nephrol. 2018 Mar;14(3):151-164 - PubMed
  5. J Am Soc Nephrol. 2003 Nov;14(11):2934-41 - PubMed
  6. J Am Soc Nephrol. 2015 Jul;26(7):1732-46 - PubMed
  7. Hypertension. 2003 Jun;41(6):1341-5 - PubMed
  8. Hypertension. 2019 Aug;74(2):331-340 - PubMed
  9. BMJ. 2009 Jul 21;339:b2535 - PubMed
  10. PLoS One. 2012;7(9):e45304 - PubMed
  11. N Engl J Med. 2015 Nov 26;373(22):2103-16 - PubMed
  12. J Hypertens. 2017 Jun;35(6):1290-1296 - PubMed
  13. Heart. 2019 Nov;105(22):1701-1708 - PubMed
  14. Lancet. 2017 Sep 16;390(10100):1151-1210 - PubMed
  15. Am J Kidney Dis. 2016 Dec;68(6):862-872 - PubMed
  16. Arch Intern Med. 2001 Sep 10;161(16):2000-5 - PubMed
  17. Am J Kidney Dis. 2014 Jan;63(1):76-83 - PubMed
  18. JAMA. 2014 Feb 5;311(5):507-20 - PubMed
  19. PLoS One. 2015 Aug 31;10(8):e0135052 - PubMed
  20. Lancet. 2005 Jan 15-21;365(9455):217-23 - PubMed
  21. Nephrol Dial Transplant. 2012 Aug;27(8):3218-23 - PubMed
  22. Hypertension. 2008 Apr;51(4):976-81 - PubMed
  23. PLoS One. 2015 Dec 15;10(12):e0144438 - PubMed
  24. Nephron. 2016;134(2):64-72 - PubMed
  25. Ann Intern Med. 2016 Oct 4;165(7):473-481 - PubMed
  26. Am J Kidney Dis. 2004 May;43(5 Suppl 1):S1-290 - PubMed
  27. PLoS Med. 2014 Oct 28;11(10):e1001750 - PubMed
  28. J Am Soc Nephrol. 2000 Feb;11(2):319-29 - PubMed
  29. Am J Kidney Dis. 2012 Mar;59(3):419-27 - PubMed
  30. Am J Physiol Renal Physiol. 2005 Nov;289(5):F941-8 - PubMed
  31. Hypertension. 2003 Nov;42(5):952-5 - PubMed
  32. Lancet. 2013 Jul 13;382(9887):158-69 - PubMed
  33. Int Urol Nephrol. 2014 Nov;46(11):2183-9 - PubMed
  34. J Am Soc Nephrol. 2005 Jan;16(1):180-8 - PubMed
  35. J Am Soc Nephrol. 2007 Jun;18(6):1928-35 - PubMed
  36. Hypertension. 2001 Feb;37(2 Pt 2):645-50 - PubMed
  37. Arch Intern Med. 2005 Oct 24;165(19):2299-304 - PubMed
  38. BMJ Open. 2016 Jul 12;6(7):e010247 - PubMed
  39. Kidney Int. 2006 Jan;69(2):375-82 - PubMed
  40. Circulation. 2016 Feb 9;133(6):584-91 - PubMed
  41. Lancet. 2018 Nov 10;392(10159):1859-1922 - PubMed
  42. PLoS One. 2016 Jun 01;11(6):e0156575 - PubMed
  43. Clin J Am Soc Nephrol. 2013 Aug;8(8):1327-35 - PubMed
  44. J Hypertens. 2014 Dec;32(12):2371-7; discussion 2377 - PubMed
  45. Ann Intern Med. 2003 Aug 19;139(4):244-52 - PubMed
  46. BMC Res Notes. 2013 Nov 13;6:463 - PubMed

MeSH terms

Publication Types